$329 Million is the total value of Krensavage Asset Management, LLC's 15 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 6.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ENTA | Sell | ENANTA PHARMACEUTICALS INC | $47,448,000 | +19.3% | 1,013,847 | -8.2% | 14.79% | +22.5% |
| GILD | Sell | GILEAD SCIENCES INC | $42,205,000 | +12.0% | 520,924 | -2.2% | 13.16% | +15.0% |
| UTHR | Buy | UNITED THERAPEUTICS CORP | $40,608,000 | +14.7% | 346,511 | +26.9% | 12.66% | +17.7% |
| Sell | BIOVERATIV INC | $35,928,000 | -15.8% | 629,540 | -11.2% | 11.20% | -13.5% | |
| SCMP | Buy | SUCAMPO PHARMACEUTICALS-CL A | $33,434,000 | +12.9% | 2,833,416 | +0.5% | 10.42% | +16.0% |
| MRK | Buy | MERCK & CO. INC. | $24,563,000 | +0.2% | 383,615 | +0.3% | 7.66% | +2.9% |
| OFIX | Sell | ORTHOFIX INTERNATIONAL NV | $23,016,000 | -15.2% | 487,101 | -16.6% | 7.17% | -12.9% |
| HYH | Sell | HALYARD HEALTH INC | $21,552,000 | -3.9% | 478,621 | -16.2% | 6.72% | -1.3% |
| RTIX | Sell | RTI SURGICAL INC | $20,083,000 | -23.1% | 4,413,821 | -1.1% | 6.26% | -21.1% |
| IVC | Buy | INVACARE CORP | $17,711,000 | +19.7% | 1,124,528 | +0.3% | 5.52% | +22.9% |
| CNMD | Sell | CONMED CORP | $10,053,000 | -12.9% | 191,601 | -15.4% | 3.13% | -10.5% |
| AVIR | AVIRAGEN THERAPEUTICS INC | $1,943,000 | +2.3% | 2,836,326 | 0.0% | 0.61% | +5.0% | |
| DRAD | DIGIRAD CORP | $1,153,000 | -14.8% | 334,179 | 0.0% | 0.36% | -12.7% | |
| JNP | JUNIPER PHARMACEUTICALS INC | $1,106,000 | -9.9% | 243,128 | 0.0% | 0.34% | -7.5% | |
| UNIS | Exit | AMGEN INC | $0 | – | -77,079 | -100.0% | -4.03% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITED THERAPEUTICS CORP | 36 | Q3 2023 | 18.1% |
| Enanta Pharmceuticals Inc | 35 | Q3 2023 | 16.7% |
| INVACARE CORP | 28 | Q3 2021 | 5.8% |
| RTI SURGICAL INC | 23 | Q2 2020 | 7.9% |
| MCKESSON CORP | 20 | Q3 2022 | 16.3% |
| BIOGEN INC | 19 | Q3 2023 | 16.0% |
| MERCK & CO. INC. | 18 | Q1 2019 | 11.1% |
| DIGIRAD CORP | 18 | Q1 2019 | 1.0% |
| REGENERON PHARMACEUTICALS | 16 | Q3 2023 | 16.1% |
| ALKERMES PLC | 16 | Q3 2023 | 14.1% |
View Krensavage Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SURGALIGN HOLDINGS, INC. | February 19, 2021 | 5,380,449 | 6.6% |
| RTI SURGICAL, INC. | February 14, 2019 | 3,852,567 | 6.1% |
| Aviragen Therapeutics, Inc. | February 15, 2018 | 2,292,058 | 5.9% |
| ENANTA PHARMACEUTICALS INC | February 15, 2017 | 883,902 | 4.6% |
| Biota Pharmaceuticals, Inc. | February 17, 2016 | 2,267,655 | 5.9% |
View Krensavage Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SCHEDULE 13G | 2024-02-27 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-15 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-16 |
| 13F-HR | 2023-02-15 |
| 13F-HR | 2022-11-15 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-17 |
| 13F-HR | 2022-02-15 |
View Krensavage Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.